Section Editors

  • Paolo Bruzzi, National Cancer Research Institute
  • Ian Cree, Warwick Medical School, Coventry
  • Shoukat Dedhar, British Columbia Cancer Agency
  • John A Hartley, University College London
  • Manami Inoue, University of Tokyo
  • Ferdinando Mannello, University Carlo Bo of Urbino
  • Christophe Nicot, Kansas University Medical Center
  • Stephen P Povoski, The Ohio State University
  • Charles Rosser, University of Hawaii Cancer Center
  • Dirk Vordermark, Martin Luther University Halle-Wittenberg

Executive Editor

  • Dafne Solera, BioMed Central

Articles

There has been an error retrieving the data. Please try again.
  • Image attributed to: From wikimedia commons, by James Heilman, MD - CC-3

    MicroRNAs in prostate cancer

    Benjamin Jackson and colleagues review our current understanding of the functional consequences of microRNA dysregulation in the development of prostate cancer, and the identification of potential microRNA targets as serum biomarkers.

    BMC Cancer 2014, 14:930
  • Image attributed to: From rcsb.org, author Wiesmann, C., CC

    Bevacizumab for elderly with mCRC

    Administration of bevacizumab plus chemotherapy in medically fit elderly German patients with metastatic colorectal cancer (mCRC) proves effective in measures of progression-free status and overall survival in a large community-based observational cohort study.

    BMC Cancer 2014, 14:761
  • Image attributed to: From Fig4D, Theisen et al, BMC Cancer 2014, 14:752

    Epigenetic drug for endometrial cancer

    A compound that reversibly inhibits lysine specific demethylase 1 (LSD1) causes global changes in histone methylation and displays anti-tumor effects on poorly differentiated endometrial carcinoma cell lines and in an orthotopic xenograft mouse model.

    BMC Cancer 2014, 14:752
  • Image attributed to: By Gleiberg, CC, wikimedia commons

    AChE -Adenovirus against gastric cancer

    Acetylcholinesterase (AChE) delivered by adenoviral vectors inhibits cell growth and induces the mitochondrial pathway of apoptosis in gastric cancer cells, represses tumor growth in mouse xenografts, and is also effective against gastric cancer stem cells.

    BMC Cancer 2014, 14:668
  • Image attributed to: From Fig1, Povoski et al, BMC Cancer 2014, 14:453 - CC

    Improving detection of lesions during surgery

    The three-sigma statistical threshold criteria method proves better than the 1.5-to-1 ratiometric threshold criteria method for determination of gamma detection probe positivity for in situ detection of abnormal tissue sites during radioguided oncologic surgery.

    BMC Cancer 2014, 14:667
  • Image attributed to: From wikimedia commons, by NCI_CC

    Barriers to breast cancer care in Mexico

    Despite the access to care programs recently implemented in Mexico, barriers to appropriate medical care still exist and affect breast cancer outcomes, contributing to the high breast cancer mortality rate in this country.

    BMC Cancer 2014, 14:658
  • Image attributed to: From wikimedia commons, by Ed Uthman - CC

    HPV test for underscreened women

    Offering HPV screening followed by cytology triage to underscreened women in developed countries could be the optimal strategy to identify women at higher risk leading to longer and safe screen intervals.

    BMC Cancer 2014, 14:574
  • Image attributed to: Fig 2 Povoski et al, BMC Cancer 2014, 14:453 - CC

    Toward real-time cancer imaging

    18F-fluorodeoxyglucose (18F-FDG) PET/CT can be successfully performed at extended injection-to-scan acquisition times while maintaining diagnostic image quality and has potential for real-time use of 18F-FDG PET/CT imaging in conjunction with interventional and surgical procedures.

    BMC Cancer 2014, 14:453

Scope

BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.

BMC Cancer is part of the BMC series which publishes subject-specific journals focused on the needs of individual research communities across all areas of biology and medicine. We offer an efficient, fair and friendly peer review service, and are committed to publishing all sound science, provided that there is some advance in knowledge presented by the work.

BMC series - open, inclusive and trusted.

Latest review

Review

Functional significance of erythropoietin in renal cell carcinoma

Christudas Morais, David W Johnson, David A Vesey, and Glenda C Gobe1

BMC Cancer 2013, 13:14 (10 January 2013)

Article Series

Submit a manuscript Sign up for article alerts Contact us

Email updates

Receive periodic news and updates relating to BioMed Central straight to your inbox.

Indexed by

  • CAS
  • DOAJ
  • Embase
  • MEDLINE
  • PubMed
  • Science Citation Index Expanded
  • Scopus

View all

ISSN: 1471-2407